Envista Holdings Corporation (NVST) exhibits 54.7% gross margins and 5.1% return on invested capital within Health Care (Medical/Dental Instruments), balanced against a 16.5x enterprise multiple and 4.8% implied options volatility.
Sustained 54.7% gross profitability converts into 7.9% operating margin and 5.1% ROIC, outpacing sector cost of capital.
ROIC: 5.1% // GM: 54.7%YoY revenue trajectory of +8.3% paired with 5.83% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +8.3% // FCF YLD: 5.83%Altman Z-Score of 1.61 and Piotroski F-Score of 9/9 indicate low near-term refinancing stress.
ALTMAN Z: 1.61 // F-SCORE: 9/9Trading at 84.1x trailing P/E (78.2x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 84.1x // EV/EBITDA: 16.5xOptions market prices a ±5.2% implied move with a 0.85 put/call ratio around $24.71 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Medical/Dental Instruments require continuous execution to defend 1.7% net margins.
NET MARGIN: 1.7% // D/E: 0.47x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for NVST & activate live FRED threshold breach alerts.